Single-Dose blitz against recurring malaria tested in conflict zone
Disease control
Completed
This study tested a strategy to control recurring malaria outbreaks in three high-risk villages in Myanmar. Researchers gave a single-dose malaria treatment (tafenoquine) to nearly all willing villagers to see if it was safe and could quickly reduce infections. The goal was to fi…
Phase: PHASE4 • Sponsor: Shoklo Malaria Research Unit • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC